**Core tip:** Several randomized controlled trials have reported the short-term advantages of laparoscopic resection compared to open resection for both colon and rectal cancer. In addition, there is evidence showing the non-inferiority of the laparoscopic approach in colon and rectal cancer surgery in long-term survival. Conversion to open surgery has been reported in up to 30% of laparoscopic colorectal cancer resections. However, both short and long-term outcomes in these patients are unclear. Therefore, we discuss the currently available evidence of the impact of conversion of laparoscopic resection for colon and rectal cancer on both short-term outcomes and long-term survival.

INTRODUCTION
============

Since its introduction in the early nineties\[[@B1]\], laparoscopic resection for colorectal cancer has increasingly gained popularity\[[@B2]\]. Large randomized controlled trials (RCTs) have proved several short-term advantages of this approach, such as less intraoperative blood loss, sooner return to bowel function and shorter hospital stay\[[@B3]-[@B5]\] and similar long-term oncologic when compared with open surgery\[[@B6]-[@B11]\].

Conversion of laparoscopic colorectal resection to open surgery has been reported in up to 30% of patients enrolled in these RCTs. However, converted patients were mostly analyzed in the laparoscopic group on an "intention-to-treat" basis. The evidence coming from the non-randomized studies that have specifically assessed the impact of conversion on both short-term and long-term outcomes (*i.e*., local recurrence rate and overall and disease-free survival) is controversial\[[@B12]-[@B29]\]. The vast majority of these studies only included a limited number of patients and did not analyze colon and rectal cancer patients separately. As a consequence, the real influence of conversion on both short-term outcomes and long-term survival outcome in colorectal cancer patients is still unclear.

The aim of this review was to summarize all the available literature with regard to the short and long-term outcome in patients who were converted during laparoscopic resection for both colon and rectal cancer and to compare these outcomes with the results in patients in whom resection was successfully completed by laparoscopy.

LITERATURE SEARCH AND STUDY SELECTION
=====================================

A search strategy of the literature was independently performed by two reviewers (Allaix ME and Furnée EJB) in MEDLINE, using the Pubmed search engine. The following search terms in title and abstract were used as free text words and Medical Subject Headings (MeSH): "colon", "rectum", "colorectal", "rectal", "conversion", "cancer", "laparoscopy" and "laparoscopic". The literature search was performed for all years, up to March 2016. The studies identified by the search strategy were subsequently selected based on title, abstract and full-text by two independent reviewers (Allaix ME and Furnée EJB).

DATA ACQUISITION
================

Data of the included studies were independently acquired by two reviewers using a standard data extraction form. The study design, number of total, laparoscopic and converted patients, sex ratio, age, body mass index and preoperative (chemo)radiation in rectal cancer patients were extracted from the individual studies. Collected intra-operative data included type of colorectal resection, reason for conversion, amount of blood loss and operative time. With regard to short-term outcome parameters, the number and type of postoperative complications, mortality rate, postoperative transfusion rate, time to return to bowel function, reoperation and readmission rate and hospital stay were collected. Based on the histological assessment of the colorectal specimen, tumor size, number of lymph nodes, presence of a positive resection margin and tumor staging according to TNM classification as well as disease stage were extracted. Regarding long-term oncologic follow-up, the number of patients available for follow-up, time to follow-up, local and distant recurrence rate and overall as well as disease-free survival were collected.

RESULTS
=======

The search strategy in MEDLINE yielded a total of 654 articles eligible for selection. Based on the in- and exclusion criteria, all articles were subsequently selected on title, abstract and full-text. Eventually, 18 studies were selected for inclusion in this review: 12 prospective\[[@B12],[@B15]-[@B17],[@B19]-[@B22],[@B24]-[@B26],[@B28]\], five retrospective cohort studies\[[@B13],[@B14],[@B18],[@B23],[@B29]\] and one prospective case-control study\[[@B27]\].

Most studies included colon as well as rectal cancer patients. Three studies only included colon cancer patients\[[@B23],[@B25],[@B29]\] and five only included rectal cancer patients\[[@B14],[@B22],[@B26],[@B20],[@B28]\]. Overall, a total number of 53329 patients were included in all individual studies. The median conversion rate was 14.3%. The median conversion rate for colon and rectal resections was 12.8% and 10.0%, respectively. Definition of conversion as well as description of surgeon's experience in laparoscopic colorectal surgery was reported in 12 studies (66.7%)\[[@B12]-[@B17],[@B19]-[@B21],[@B23],[@B24],[@B26]-[@B28]\]. The baseline characteristics of the individual studies are reported in Table [1](#T1){ref-type="table"}. Three studies reported significantly more male patients in the converted group (CG) compared to the laparoscopic group (LG)\[[@B14],[@B16],[@B29]\]. The body mass index (BMI) was significantly higher in the CG in five studies\[[@B14],[@B18],[@B20],[@B27],[@B28]\]. Neo-adjuvant chemo-radiation in rectal cancer patients was significantly more frequently applied in the CG in the study by Keller et al\[[@B22]\] (*n =* 63, 54.3% *vs n =* 19, 76.0%) and in the LG in the study by Rottoli et al\[[@B20]\] (*n =* 33, 22.4% *vs n =* 1, 3.8%). There were no significant differences between both groups in the other six studies reporting this item\[[@B13]-[@B16],[@B19],[@B26]\].

###### 

Baseline characteristics of individual studies

  **Ref**.                     **Study design**                              **Colon and/or rectal**   **No. patients**   **Conversion (%)**   **Men (%)**   **Age (yr)**   **BMI (kg/m[2](#T1FN2){ref-type="table-fn"})**                                                                                                      
  ---------------------------- --------------------------------------------- ------------------------- ------------------ -------------------- ------------- -------------- ------------------------------------------------ ------------- -------------------------------------- ------ -------------------------------------- ------
  Allaix et al\[[@B13]\]       Retrospective                                 Both                      1114               122 (10.9)           77 (10.7)     45 (11.4)      530 (53.4)                                       69 (56.6)     67.0[1](#T1FN1){ref-type="table-fn"}   68.0   23.0                                   24.0
  Agha et al\[[@B14]\]         Retrospective                                 Rectal                    300                26 (8.6)             NA            26 (8.6)       166 (60.5)[1](#T1FN1){ref-type="table-fn"}       21 (80.7)     64.7                                   64.5   26.2[1](#T1FN1){ref-type="table-fn"}   29.0
  Biondi et al\[[@B12]\]       Prospective                                   Both                      207                33 (15.9)            14 (42.4)     19 (57.6)      102 (58.6)                                       23 (69.7)     65.5                                   66.8   NR                                     NR
  Bouvet et al\[[@B15]\]       Prospective                                   Both                      91                 38 (41.1)            NR            NR             30 (56,6)                                        25 (65.8)     65.0                                   67.0   NR                                     NR
  Chan et al\[[@B16]\]         Prospective                                   Both                      470                41 (8.7)             NR (12.3)     NR (7.2)       238 (55.5)[1](#T1FN1){ref-type="table-fn"}       30 (73.2)     69.0                                   69.1   NR                                     NR
  Franko et al\[[@B21]\]       Prospective                                   Both                      174                31 (17.8)            NR            NR             73 (51.0)                                        21 (51.2)     70.0                                   69.0   NR                                     NR
  Keller et al\[[@B22]\]       Prospective                                   Rectal                    141                25 (17.7)            NA            25 (17.7)      63 (54.3)                                        17 (68.0)     63.1                                   63.5   28.7                                   27.5
  Li et al\[[@B23]\]           Retrospective                                 Colon                     217                33 (15.2)            33 (15.2)     NA             94 (51.1)                                        20 (60.7)     62.6                                   62.9   25.6                                   24.5
  Martínek et al\[[@B17]\]     Prospective                                   Both                      243                17 (7.0)             10 (6.3)      7 (8.2)        146 (64.6)                                       13 (76.5)     64.5                                   62.8   26.7                                   28.4
  Moloo et al\[[@B24]\]        Prospective                                   Both                      359                46 (12.8)            NR            NR             171 (54.6)                                       25 (54.3)     65.0                                   65.0   NR                                     NR
  Ptok et al\[[@B25]\]         Prospective                                   Colon                     346                56 (16.2)            56 (16.2)     NA             NR                                               NR            66.5                                   68.9   NR                                     NR
  Rickert et al\[[@B26]\]      Prospective                                   Rectal                    162                38 (23.5)            NA            38 (23.5)      69 (55.7)                                        27 (71.0)     63.0[1](#T1FN1){ref-type="table-fn"}   69.0   25.1                                   25.8
  Rottoli et al\[[@B20]\]      Prospective                                   Rectal                    173                26 (15.0)            NA            26 (15.0)      NR                                               NR            63.2                                   64.3   24.9[1](#T1FN1){ref-type="table-fn"}   27.3
  Rottoli et al\[[@B27]\]      Prospective[2](#T1FN2){ref-type="table-fn"}   Both                      93                 31 (NA)              NR            NR             37 (59.7)                                        24 (77.4)     72.0                                   72.0   26.8[1](#T1FN1){ref-type="table-fn"}   29.6
  Scheidbach et al\[[@B18]\]   Retrospective                                 Both                      1409               80 (5.7)             41 (8.2)      39 (6.4)       658 (49.5)                                       46 (57.5)     68.9                                   69.7   25.2[1](#T1FN1){ref-type="table-fn"}   26.4
  White et al\[[@B19]\]        Prospective                                   Both                      175                25 (14.3)            NR            NR             70 (46.7)                                        11 (44.0)     69.7                                   74.4   27.2                                   26.9
  Yamamoto et al\[[@B28]\]     Prospective                                   Rectal                    1073               78 (7.3)             NA            78 (7.3)       625 (62.8)                                       48 (61.5)     62.9                                   63.8   22.7[1](#T1FN1){ref-type="table-fn"}   24.6
  Yerokun et al\[[@B29]\]      Retrospective                                 Colon                     46472              6144 (13.2)          6144 (13.2)   NA             19738 (48.9)[1](#T1FN1){ref-type="table-fn"}     3308 (53.8)   70.0[1](#T1FN1){ref-type="table-fn"}   69.0   NR                                     NR

*P* value of difference between overall LAP and CONV is \< 0.05;

Case-control study. BMI: Body mass index; NR: Not reported; NA: Not applicable; LAP: Laparoscopic group; CONV: Converted group.

Type of colorectal resection
----------------------------

The type of colorectal resection performed in the individual patients was only reported in eight studies (44.4%). In all patients who underwent a colon resection in the LG, 362 (39.0%) had a right hemicolectomy, 271 (29.2%) a left hemicolectomy and 295 (31.8%) a sigmoid colon resection. The number of different colonic resections in the CG was 60 (42.6%), 40 (28.4%) and 41 (29.1%), respectively. In the rectal resection group, low anterior resection was performed in 1636 patients (82.6%) in the LG and 185 (80.4%) in the CG, abdominoperineal resection in 323 (16.3%) and 39 (17.0%), and Hartmann's procedure in 22 (1.1%) and 6 (2.6%), respectively.

Reasons for conversion and intra-operative data
-----------------------------------------------

The reason for conversion was reported in 16 studies (88.9%) (Table [2](#T2){ref-type="table"}). In more than half of them, tumor related aspects were the most frequent reason for conversion\[[@B12],[@B13],[@B18]-[@B20],[@B23],[@B24],[@B25],[@B27]\].

###### 

Reason for conversion, intra-operative blood loss and operative time

  **Ref**.                     **Tumor related (%)**   **Anatomic related (%)**   **Intra-operative complication (%)**   **Obesity (%)**   **Adhesions (%)**   **Other reason (%)**   **Intra-operative blood loss (mL)**   **Duration of operation (min)**                                                                                           
  ---------------------------- ----------------------- -------------------------- -------------------------------------- ----------------- ------------------- ---------------------- ------------------------------------- --------------------------------- --------------------------------------- ------- --------------------------------------- -------
  Allaix et al\[[@B13]\]       59 (48.4)               44 (57.1)                  15 (33.3)                              6 (4.9)           5 (4.1)             23 (18.8)              18 (14.8)                             11 (9.0)                          100[1](#T2FN1){ref-type="table-fn"}     150     140[1](#T2FN1){ref-type="table-fn"}     180
  Agha et al\[[@B14]\]         0 (0)                   0 (0)                      0 (0)                                  0 (0)             5 (19.2)            10 (38.5)              4 (15.4)                              7 (26.9)                          NR                                      NR      215[1](#T2FN1){ref-type="table-fn"}     258
  Biondi et al\[[@B12]\]       17 (51.5)               NR                         NR                                     3 (9.1)           6 (18.2)            0 (0)                  6 (18.2)                              1 (3.0)                           96.4[1](#T2FN1){ref-type="table-fn"}    184     162.0[1](#T2FN1){ref-type="table-fn"}   187.9
  Bouvet et al\[[@B15]\]       6 (15.8)                NR                         NR                                     10 (26.3)         2 (5.3)             0 (0)                  12 (31.6)                             8 (21.1)                          NR                                      NR      240                                     270
  Chan et al\[[@B16]\]         11 (26.9)               NR                         NR                                     4 (9.8)           6 (14.7)            0 (0)                  14 (34.1)                             6 (14.7)                          191.2[1](#T2FN1){ref-type="table-fn"}   461.9   179.4                                   187.2
  Franko et al\[[@B21]\]       4 (12.9)                NR                         NR                                     18 (58.1)         5 (16.1)            0 (0)                  NR                                    4 (12.9)                          NR                                      NR      160[1](#T2FN1){ref-type="table-fn"}     182
  Keller et al\[[@B22]\]       NR                      NR                         NR                                     NR                NR                  NR                     NR                                    NR                                74[1](#T2FN1){ref-type="table-fn"}      253     242.6[1](#T2FN1){ref-type="table-fn"}   260
  Li et al\[[@B23]\]           15 (45.5)               15 (45.5)                  NA                                     4 (12.1)          4 (12.1)            0 (0)                  10 (30.3)                             0 (0)                             90[1](#T2FN1){ref-type="table-fn"}      147     165[1](#T2FN1){ref-type="table-fn"}     188
  Martínek et al\[[@B17]\]     3 (17.6)                NR                         NR                                     6 (35.3)          5 (29.4)            NR                     NR                                    3 (17.6)                          177[1](#T2FN1){ref-type="table-fn"}     415     152[1](#T2FN1){ref-type="table-fn"}     224
  Moloo et al\[[@B24]\]        13 (28.3)               NR                         NR                                     12 (26.1)         4 (8.7)             0 (0)                  5 (10.9)                              11 (23.9)                         NR                                      NR      NR                                      NR
  Ptok et al\[[@B25]\]         15 (26.8)               15 (26.8)                  NA                                     8 (14.3)          7 (12.5)            0 (0)                  9 (16.1)                              17 (30.4)                         NR                                      NR      178.9                                   186.7
  Rickert et al\[[@B26]\]      7 (18.4)                NA                         7 (18.4)                               11 (28.9)         4 (10.5)            6 (15.8)               6 (15.8)                              4 (10.5)                          NR                                      NR      345                                     363
  Rottoli et al\[[@B20]\]      7 (26.9)                NA                         7 (26.9)                               10 (23.5)         6 (23.1)            0 (0)                  2 (7.7)                               1 (3.8)                           NR                                      NR      285[1](#T2FN1){ref-type="table-fn"}     342
  Rottoli et al\[[@B27]\]      12 (38.7)               NR                         NR                                     6 (19.3)          2 (6.5)             0 (0)                  11 (35.5)                             0 (0)                             NR                                      NR      NR                                      NR
  Scheidbach et al\[[@B18]\]   24 (30.0)               NR                         NR                                     8 (10.0)          14 (17.5)           0 (0)                  15 (18.8)                             19 (23.7)                         200[1](#T2FN1){ref-type="table-fn"}     500     180[1](#T2FN1){ref-type="table-fn"}     232
  White et al\[[@B19]\]        18 (72.0)               NR                         NR                                     0 (0)             4 (12.0)            0 (0)                  3 (12.0)                              0 (0)                             NR                                      NR      145.6[1](#T2FN1){ref-type="table-fn"}   172
  Yamamoto et al\[[@B28]\]     13 (16.7)               NA                         13 (16.7)                              26 (33.3)         7 (9.0)             12 (15.4)              10 (12.8)                             10 (12.8)                         80[1](#T2FN1){ref-type="table-fn"}      265     270[1](#T2FN1){ref-type="table-fn"}     295
  Yerokun et al\[[@B29]\]      NR                      NR                         NA                                     NR                NR                  NR                     NR                                    NR                                NR                                      NR      NR                                      NR

*P* value of difference between LAP and CONV is \< 0.05. NR: Not reported; NA: Not applicable; LAP: Laparoscopic group; CONV: Converted group.

Intra-operative blood loss was reported in eight studies and ranged from 74 mL to 200 mL in the LG and from 147 mL to 500 mL in the CG. In all eight studies, intra-operative blood loss was significantly less in the LG compared to the CG (Table [2](#T2){ref-type="table"}). Duration of surgery was significantly shorter in the LG in 11 of 15 studies reporting the operative time (Table [2](#T2){ref-type="table"}).

Short-term postoperative outcomes
---------------------------------

Several studies have compared the short-term outcomes of laparoscopic colorectal resections converted to open surgery to those achieved after laparoscopically completed colorectal resection, reporting controversial results. Postoperative complication rate ranged from 6.0% to 36.8% in the LG and from 15.4% to 61.2% in the CG (Table [3](#T3){ref-type="table"}). In five studies (21.7%), postoperative complications occurred more frequently in the CG than in the LG\[[@B14],[@B16],[@B18],[@B22],[@B28]\], while 8 studies did not find any significant difference\[[@B12],[@B13],[@B15],[@B17],[@B20],[@B25]-[@B27]\]. The wound infection rate was significantly lower in the LG in four out of ten studies reporting this topic\[[@B12],[@B14],[@B18],[@B26]\]. A significant difference in anastomotic leakage rate was found in only one out of 11 studies, in favor of the LG (5.0% *vs* 13.8%)\[[@B18]\]. With regard to prolonged postoperative ileus, there was only one out of six studies reporting a significant difference in favor of the LG (1.1% *vs* 9.1%)\[[@B12]\]. Urologic and cardiopulmonary complications were reported in six studies (33.3%) and no significant differences were found between both groups\[[@B13],[@B14],[@B16],[@B18],[@B22],[@B26],[@B28]\]. Return to bowel function was only reported in four studies\[[@B12],[@B13],[@B18],[@B23]\], and in two of them\[[@B18],[@B23]\] bowel function returned significantly sooner in the LG (2.3 d *vs* 3.4 d and 3 d *vs* 4 d, respectively).

###### 

Postoperative data

  **Ref**.                     **Postoperative complications (%)**          **Wound** **infection (%)**   **Anastomotic** **leakage (%)**              **Mortality** **(30-d) (%)**   **Hospital** **stay (d)**                                                                                                                            
  ---------------------------- -------------------------------------------- ----------------------------- -------------------------------------------- ------------------------------ ------------------------------------------ ----------- ------------------------------------------- ----------- ------------------------------------- ------
  Allaix et al\[[@B13]\]       156 (15.7)                                   20 (16.4)                     9 (0.9)                                      3 (2.5)                        49 (4.9)                                   4 (3.3)     3 (0.3)                                     1 (0.8)     7                                     9
  Agha et al\[[@B14]\]         101 (36.8)[1](#T3FN1){ref-type="table-fn"}   16 (61.2)                     33 (12.0)[1](#T3FN1){ref-type="table-fn"}    6 (23.0)                       23 (8.3)                                   3 (11.5)    0 (0)                                       0 (0)       10                                    10.5
  Biondi et al\[[@B12]\]       10 (6.0)                                     11 (33.3)                     1 (0.6)[1](#T3FN1){ref-type="table-fn"}      2 (6.1)                        3 (1.7)                                    1 (3.0)     NR                                          NR          8.4[1](#T3FN1){ref-type="table-fn"}   10.6
  Bouvet et al\[[@B15]\]       13 (24.5)                                    10 (26.3                      NR                                           NR                             NR                                         NR          1 (1.9)                                     0 (0)       6[1](#T3FN1){ref-type="table-fn"}     8
  Chan et al\[[@B16]\]         72 (16.7)[1](#T3FN1){ref-type="table-fn"}    23 (56.1)                     8 (1.9)                                      6 (2.4)                        10 (2.3)                                   1 (2.4)     1 (0.2)                                     1 (2.4)     6[1](#T3FN1){ref-type="table-fn"}     10
  Franko et al\[[@B21]\]       NR                                           NR                            NR                                           NR                             NR                                         NR          1 (0.7)                                     2 (6.5)     4.0[1](#T3FN1){ref-type="table-fn"}   6.8
  Keller et al\[[@B22]\]       25 (21.5)[1](#T3FN1){ref-type="table-fn"}    8 (32.0)                      2 (1.7)                                      4 (20.0)                       3 (2.6)                                    0 (0)       1 (0.9)                                     0 (0)       4.4[1](#T3FN1){ref-type="table-fn"}   6.8
  Li et al\[[@B23]\]           NR                                           NR                            4 (2.2)                                      3 (9.1)                        14 (7.6)                                   3 (9.1)     NR                                          NR          4[1](#T3FN1){ref-type="table-fn"}     8
  Martínek et al\[[@B17]\]     65 (28.8)                                    6 (35.3)                      NR                                           NR                             NR                                         NR          7 (3.1)                                     0 (0)       11.3                                  12.5
  Moloo et al\[[@B24]\]        NR                                           NR                            NR                                           NR                             NR                                         NR          NR                                          NR          NR                                    NR
  Ptok et al\[[@B25]\]         75 (25.9)                                    22 (39.3)                     NR                                           NR                             NR                                         NR          1 (0.3)                                     1 (1.8)     NR                                    NR
  Rickert et al\[[@B26]\]      42 (33.9)                                    19 (50.0)                     6 (4.8)[1](#T3FN1){ref-type="table-fn"}      7 (18.4)                       18 (16.4)                                  7 (22.6)    0 (0)                                       1 (2.6)     12[1](#T3FN1){ref-type="table-fn"}    15
  Rottoli et al\[[@B20]\]      34 (23.1)                                    4 (15.4)                      NR                                           NR                             17 (11.6)                                  4 (15.4)    0 (0)                                       0 (0)       8                                     9
  Rottoli et al\[[@B27]\]      13 (21.0)                                    7 (22.6)                      NR                                           NR                             1 (1.6)                                    1 (3.2)     1 (1.6)                                     0 (0)       NR                                    NR
  Scheidbach et al\[[@B18]\]   389 (28.5)[1](#T3FN1){ref-type="table-fn"}   41 (51.3)                     138 (10.4)[1](#T3FN1){ref-type="table-fn"}   16 (20.0)                      67 (5.0)[1](#T3FN1){ref-type="table-fn"}   11 (13.8)   20 (1.5)[1](#T3FN1){ref-type="table-fn"}    4 (5.0)     NR                                    NR
  White et al\[[@B19]\]        NR                                           NR                            14 (9.3)                                     5 (20.0)                       NR                                         NR          0 (0)                                       1 (4.0)     8.3[1](#T3FN1){ref-type="table-fn"}   14.4
  Yamamoto et al\[[@B28]\]     210 (21.1)[1](#T3FN1){ref-type="table-fn"}   34 (43.6)                     56 (5.6)                                     14 (17.9)                      72 (7.2)                                   14 (17.9)   0 (0)                                       0 (0)       14[1](#T3FN1){ref-type="table-fn"}    20
  Yerokun et al\[[@B29]\]      NR                                           NR                            NR                                           NR                             NR                                         NR          419 (1.0)[1](#T3FN1){ref-type="table-fn"}   115 (1.9)   5[1](#T3FN1){ref-type="table-fn"}     6

*P* value of difference between LAP and CONV is \< 0.05. NR: Not reported; LAP: Laparoscopic group; CONV: Converted group.

In four out of six studies, postoperative transfusion was necessary in significantly more patients in the CG\[[@B13],[@B14],[@B18],[@B21]\], whereas no significant difference between both groups was found in the other two studies\[[@B20],[@B27]\]. A previous pooled analysis of these data showed that converted patients were more likely to require postoperative blood transfusion than patients undergoing completed laparoscopic resection\[[@B30]\]. The 30-d mortality rate was not significantly different between both groups in most studies, although a significant difference in favor of the LG was found in three studies\[[@B18],[@B21],[@B29]\]. A previous meta-analysis of seven studies including 1655 patients showed that converted patients had a higher risk of 30-d mortality than patients with laparoscopically completed colorectal resection\[[@B30]\].

There was a range in reoperation rate in the LG from 4.9% to 17.7% and from 0% to 15.0% in the CG. Only one study reported a significant difference between both groups, in favor of LG (4.9% *vs* 15.0%)\[[@B18]\]. In 10 out of 14 studies, the hospital stay was significantly shorter in the LG\[[@B12],[@B15],[@B16],[@B19],[@B21]-[@B23],[@B26],[@B28],[@B29]\], whilst no significant difference was present in the remaining studies\[[@B13],[@B14],[@B17],[@B20]\]. The readmission rate was only reported in three studies\[[@B21],[@B22],[@B29]\]. A significant difference was found in one, in favor of the LG (5.0% *vs* 7.5%)\[[@B29]\]. The interpretation of these data is made difficult by several factors, including heterogeneous definitions of conversion, size and nature of the studies that in most cases did not separately analyze colon and rectal cancer patients.

Only a few studies assessed factors that might affect morbidity after conversion of laparoscopic colorectal resections. Aytac et al\[[@B31]\] performed a retrospective review of 2483 patients undergoing laparoscopic colorectal resection. A total of 270 were converted to open surgery. A high ASA score, previous abdominal surgery but not conversion were independently associated with postoperative complications. Among patients who required conversion to open surgery, smoking, cardiac co-morbidities, hypertension, previous abdominal surgery and intra-operative adhesions were factors significantly associated with increased postoperative complications. Patients who suffered postoperative complications had a significantly shorter time to conversion. However, it is worth to note that patients undergoing conversion within 50 min from the beginning of the operation were older and were more likely to have co-morbidities.

**Conversion in colon cancer:** When considering colon cancer patients, three large studies did not report significant differences in short-term outcomes\[[@B23],[@B25],[@B29]\]. Guillou et al\[[@B5]\] analyzed the short-term results of the Medical Research Council (MRC) CLASICC trial reporting similar rates of postoperative morbidity among 61 converted patients and 185 who had a completed laparoscopic colon resection (38% *vs* 34%). Our group\[[@B13]\] recently compared the early outcomes in 641 patients who had a completed laparoscopic colon resection and in 77 converted patients. No significant differences were observed in complication rate: 12.9% *vs* 14.5%, respectively (*P =* 0.864). Median length of hospital stay was 7 d *vs* 8 d, respectively (*P =* 0.303). Similar results were reported by Ptok et al\[[@B25]\] in a prospective study comparing 290 patients with completed laparoscopic colon resection and 56 converted patients: morbidity rate was 26% *vs* 39% and mortality rate was 1.8% *vs* 0.3%, respectively. Conversely, a retrospective review of the United States National Cancer Data Base including 40328 patients treated by completed laparoscopic colon resection and 6144 converted patients, found a slightly longer hospital stay (median 4 d *vs* 3 d) and higher rates of both readmission within 30 d (7.5% *vs* 5%) and mortality at 30 d (1.9% *vs* 1%) in the group of converted patients\[[@B29]\].

**Conversion in rectal cancer:** Only one RCT\[[@B5]\] and a few studies\[[@B14],[@B22],[@B28]\] focused on patients undergoing laparoscopic resection for rectal cancer, reporting worse short term outcomes in case of conversion to open surgery. The short-term results of the MRC CLASICC trial showed a higher 30-d postoperative complication rate in 82 converted patients compared to 160 patients who had a laparoscopic completed rectal resection: transfusion requirement, wound infections, pulmonary infection and anastomotic leakage rate were increased in converted patients\[[@B5]\]. Hospital stay was longer in these patients. Agha et al\[[@B14]\] analyzed rectal cancer patients undergoing elective laparoscopic rectal surgery. The overall complication rate was higher in the group of converted patients. Perioperative blood transfusions were needed in 11.5% of converted patients and in 1.9% of patients undergoing a completed laparoscopic rectal resection (*P =* 0.001). Wound infections occurred more frequently in converted patients (23% *vs* 12%, *P =* 0.01). Yamamoto et al\[[@B28]\] retrospectively reviewed 1073 patients undergoing laparoscopic surgery for rectal cancer. The postoperative morbidity rate was significantly higher after conversion: 43.6% *vs* 21.1%. The most common complications in converted patients were wound infection (17.9%), anastomotic leakage (17.9%) and small bowel obstruction (10.3%). The rate of these complications in the group of patients who had a completed laparoscopic rectal resection was 7.2% for anastomotic leakage, 5.6% for wound infection and 3.0% for small bowel obstruction. Resumption of gastrointestinal functions was significantly prolonged in the case of conversion and median length of hospital stay was significantly longer (20 d *vs* 14 d, *P =* 0.010). Similar results were observed by others\[[@B22]\].

**Reactive *vs* pre-emptive conversion:** The outcomes after a reactive or a pre-emptive conversion are poorly studied. Yang et al\[[@B32]\] matched 30 patients who had undergone a reactive conversion for several reasons including bleeding, bowel injury, ureter damage or splenic injury with 60 patients who had pre-emptive conversion and 60 patients who had a laparoscopically completed colorectal resection. After a reactive conversion, patients more frequently had a postoperative complication (50% *vs* 26.7%, *P =* 0.028), later resumption of a regular diet (6 d *vs* 5 d, *P =* 0.033) and a trend towards a longer hospital stay (8.1 d *vs* 7.1 d, *P =* 0.08) than patients who had a pre-emptive conversion. Aytac et al\[[@B31]\] found that reactive conversion was associated with a higher risk of postoperative pneumonia, bleeding and need for reoperation compared to patients requiring pre-emptive conversion to open surgery. Overall morbidity, length of hospital stay and readmission rates were slightly worse in patients with reactive conversion, even though the differences did not reach statistical significance.

The increased rate of postoperative morbidity after reactive conversion might be related to the sequelae of the intraoperative complication that leads to a reactive conversion, suggesting that a low threshold for conversion is advisable in challenging cases, thus avoiding a dangerous and lengthy dissection. However, the best timing of conversion is unclear. Belizon et al\[[@B33]\] found that the postoperative morbidity rate significantly decreased if the decision to convert was taken within or after the first 30 min of the procedure (40% *vs* 86.9%, *P \<* 0.05). Conversely, Aytac et al\[[@B31]\] reported that timing of conversion did not adversely affect the postoperative outcomes: 72 patients converted within the first 30 min had similar overall morbidity, reoperation and readmission rates as 198 patients who had late conversion. However, the interpretation of these findings is biased by the fact that several patients in both groups underwent reactive conversion. Further studies are needed to better clarify the real impact of conversion timing on the postoperative course.

**Converted *vs* open colorectal resection:** While several studies have compared the short-term outcomes after conversion in laparoscopic colorectal resection to those observed after laparoscopically completed colorectal resection, there are limited data on the effects of conversion compared to planned open surgery. The evidence is controversial with some studies showing a worse postoperative course in converted patients and others reporting no significant differences\[[@B34]\]. In particular, among 4 studies that included only rectal cancer patients, one found better results in converted patients\[[@B35]\], one reported better outcomes after planned open rectal resection\[[@B36]\] and two found no differences\[[@B26],[@B37]\]. Recently, Giglio et al\[[@B34]\] conducted a systematic review and meta-analysis of short term outcomes after laparoscopic converted or open colorectal resection. The aim was to determine if conversion is a drawback or a complication of laparoscopic colorectal resection burdened by additional postoperative morbidity. The authors identified 20 studies including a total of 30656 patients undergoing open surgery and 11085 having laparoscopic colorectal resection. A total of 1935 patients (17%) in the laparoscopic group were converted to open surgery. Colorectal cancer was the indication for surgery in 13 of the studies included in this meta-analysis, while both benign and malignant diseases were included in seven. A total of five studies only included rectal cancer patients, while other five only analyzed colon resections. The risk of bias was moderate to high in 11 studies. No differences in 30-d mortality and 30-d morbidity rates were found. While a higher rate of wound infection was observed among converted patients, no significant differences were observed between both groups in length of hospital stay, anastomotic leakage, postoperative bleeding, sepsis, cardiac complications, deep venous thrombosis and reoperation rates. Subgroup analyses on mortality, overall morbidity and length of hospital stay according to the site of disease (colon *vs* rectum), and indication for surgery (cancer *vs* benign disease) showed that the short-term outcomes in converted patients were comparable to those observed in patients treated by open surgery. The learning curve of the surgeon and the reason for conversion did not show any adverse impact on the postoperative course of converted patients.

Very recently, Masoomi et al\[[@B38]\] published the results of a retrospective analysis of 646414 patients from the United States National Inpatient Sample undergoing laparoscopic (27.7%) or open colorectal resection for both benign and malignant diseases. The conversion rate of laparoscopic to open surgery was 16.6%. They found that the group of converted patients had significantly better outcomes compared to the open group, with a lower in-hospital mortality rate. Even though the length of hospital stay was similar between the two groups, the median total hospital charge was \$2800 higher in the converted group compared to the open group. Similar results were reported by Yerokun et al\[[@B29]\] who used the United States National Cancer Data Base to identify patients undergoing elective colon resection for stage I-III colon cancer between 2010 and 2012. Of 104400 patients, 40328 (38.6%) underwent laparoscopic colectomy, 57928 (55.5%) open colectomy and 6144 (5.9%) converted colectomy. After adjustment for patient, clinical and treatment characteristics, conversion to open surgery was associated with a significantly reduced 30-d mortality (1.9% *vs* 2.8%, *P \<* 0.001), a shorter hospital stay and a reduced 30-d readmission rate (5.9% *vs* 7.5%, *P \<* 0.001) when compared to open surgery.

Since converted colon resection is still associated with better outcomes than planned open colon resection, the authors concluded that the laparoscopic approach in patients with colon cancer should be attempted in all cases with no contraindications to laparoscopy. Even though there is increasing evidence showing that conversion of laparoscopic colon resection does not impair short-term outcomes, the data are not definitive and robust data regarding conversion of laparoscopic rectal resection are missing. While waiting further studies to confirm these results and to shed more light on the impact of conversion of laparoscopic rectal resections, several studies have been conducted aiming to identify risk factors for conversion. Algorithms to predict conversion from laparoscopic colorectal resection to open surgery have been proposed; however, most of them are not specific for colorectal cancer\[[@B39]-[@B41]\]. To date, only a few studies have been focused on predictors of conversion in patients with colon or rectal cancer. Thorpe et al\[[@B42]\] analyzed the data from the MRC Conventional *vs* Laparoscopic-Assisted Surgery in Colorectal Cancer (CLASICC). They found that locally advanced tumor, BMI, and ASA score greater than 3 were independent risk factors for conversion in colon cancer patients. Similarly, BMI and male sex were independently associated with conversion in rectal cancer patients. BMI was also identified as risk factor for conversion in rectal cancer patients by Yamamoto et al\[[@B28]\] in a retrospective analysis of 1073 rectal cancer patients.

A model to predict conversion to open surgery during laparoscopic rectal resection for cancer was proposed by Zhang et al\[[@B43]\]. Six possible risk factors for conversion were extracted from a review of the literature and a series of 602 laparoscopic rectal resections, including male sex, surgical experience (at least 25 previous laparoscopic rectal resections), previous open abdominal surgery, BMI ≥ 28, tumor diameter ≥ 6 cm, and tumor invasion, for which a score of relevance was assigned. Further studies however are needed to confirm this model.

Histological outcome of the colorectal specimen
-----------------------------------------------

The tumor (T) stage was reported in 10 studies (55.6%)\[[@B12]-[@B17],[@B19],[@B23],[@B25],[@B27]\]. In most of them (*n* = 7), no significant differences in T-stage were found between both groups. In the study by Allaix et al\[[@B13]\], T1 was significantly more frequent in the LG (*n =* 345, 34.8% *vs n =* 9, 7.4%), whilst T3 and T4 were significantly more frequent in the CG (*n =* 446, 45.0% *vs n =* 85, 69.7% for T3, and *n =* 37, 3.7% *vs n =* 15, 12.3% for T4, respectively). Agha et al\[[@B14]\] found significantly more T2-tumors in the LG (*n =* 87, 31.7% *vs n =* 5, 19.2%) and significantly more T4-tumors in the CG (*n =* 10, 3.6% *vs n =* 6, 23.0%). In the study by Bouvet et al\[[@B15]\], T4-tumors were significantly more frequent in the CG (*n =* 1, 1.9% *vs n =* 5, 13.2%), whilst the other T-stages were comparable between both groups in this study.

The number of lymph nodes harvested was similar between both groups in all 13 studies reporting this item\[[@B12],[@B13],[@B15]-[@B17],[@B20]-[@B23],[@B26]-[@B29]\]. The number of harvested lymph nodes ranged from 8 to 20.2 in the LG and from 9 to 22.4 in the CG. The N-stage was reported in five studies (27.8%)\[[@B12],[@B13],[@B20],[@B25],[@B26]\]; in two of these studies\[[@B12],[@B13]\], the N0-stage was significantly more frequent in the LG (*n =* 679, 68.4% *vs n =* 67, 54.9% and *n =* 92, 52.9% *vs n =* 8, 24.2%, respectively).

The tumor size ranged from 3.5 to 5.1 cm in the LG and from 3.5 to 5.6 cm in the CG. In three out of seven studies (42.9%), the tumor size was significantly larger in the CG (5.3 cm *vs* 3.9 cm, 5.0 cm *vs* 4.0 cm and 4.0 cm *vs* 3.7 cm, respectively)\[[@B12],[@B16],[@B29]\]. Tumor margin status was also reported in seven studies\[[@B13],[@B14],[@B17],[@B20],[@B26],[@B27],[@B29]\] and in one of these, tumor margin positivity was significantly more frequent in the CG (*n =* 319, 5.2% *vs n =* 1075, 2.7%)\[[@B29]\].

Disease stage was reported in all studies, although incomplete in two\[[@B20],[@B18]\]. In seven studies, stage I-III patients were included\[[@B12],[@B13],[@B19],[@B21],[@B23],[@B25],[@B29]\], in three stage I-IV\[[@B14],[@B17],[@B24]\], in four studies stage 0-IV\[[@B15],[@B16],[@B22],[@B28]\] and in two studies stage 0-III\[[@B26],[@B27]\]. In three studies\[[@B12],[@B13],[@B29]\], disease stage I was significantly more frequent in the LG, whilst stage III was more frequent in the CG. In the studies by Biondi et al\[[@B12]\] and Yerokun et al\[[@B29]\], stage II was also significantly more frequent in the LG. In the studies by Agha et al\[[@B14]\] and Rottoli et al\[[@B20]\], stage IV disease was significantly more frequent in the CG as well.

Long-term oncologic outcome
---------------------------

**Survival:** Most of the studies reported one or more long-term oncologic outcome measures. Overall survival (OS) was reported in fourteen studies\[[@B12],[@B13],[@B16]-[@B27]\] (Figure [1](#F1){ref-type="fig"}). The median 5-year OS was 79.7% (61.0%-99.1%) in the LG and 70.2% (38.0%-100%) in the CG. OS was in favor of the patients in the LG in all studies, except in the study by Keller et al\[[@B22]\], who reported an extremely high OS in both groups. However, there was a statistically significant difference in OS in only three studies in favor of the LG\[[@B12],[@B13],[@B18]\]. The lack of significance in OS between LG and CG in the other series might be caused by the small number of patients included, as two of the studies reporting a significant difference in OS were very large studies including more than one thousand patients\[[@B13],[@B18]\]. Additionally, the interpretation of the outcome with regard to OS is also complicated by the fact that in most studies colon as well as rectal cancer patients were included. OS was reported in three of the five studies only including rectal cancer patients\[[@B20],[@B22],[@B26]\] and in two of the three studies in which only colon cancer patients were included\[[@B23],[@B25]\]. In none of these studies, there was a significant difference in OS found between the laparoscopic and converted group.

![Overall survival rates reported in the individual studies. ^a^*P* value of difference between the laparoscopic and converted group is \< 0.05; ^b^3-yr overall survival rates, the other studies reported 5-yr overall survival rates.](WJG-22-8304-g001){#F1}

The 5-year disease-free survival (DFS) was reported in ten studies\[[@B12],[@B13],[@B16]-[@B20],[@B23],[@B25],[@B27]\], whilst 3 and 2-year DFS was reported in two\[[@B14],[@B22]\] and one study\[[@B15]\], respectively (Figure [2](#F2){ref-type="fig"}). The median DFS was 81.3% (55.5%-93.1%) in the LG and 65.6% (38.0%-100%) in the CG. DFS was in favor of the LG in all, except two studies\[[@B18],[@B22]\]. A statistical significant difference was found in five of the studies reporting a favorable outcome in the LG (Figure [2](#F2){ref-type="fig"}).

![Disease-free survival rates reported in the individual studies. ^a^*P* value of difference between the laparoscopic and converted group is \< 0.05; ^b^3-yr and ^c^2-yr disease-free survival rates, the other studies reported 5-yr disease-free survival rates.](WJG-22-8304-g002){#F2}

The significant worse OS and DFS in the CG might be related to several factors other than conversion itself, including a locally advanced tumor\[[@B30]\]. We performed a multivariate analysis of predictors of survival in our study and found pT4 tumor stage and a positive lymph node ratio ≥ 0.25, but not conversion itself as independent predictors of poor OS and DFS\[[@B13]\]. In addition, an adverse survival in converted patients might be explained by a more extensive inflammatory response due to more tissue damage as well as a higher postoperative complication rate compared to the laparoscopic group of patients\[[@B30]\].

**Recurrence:** The local and distant recurrence rate was also reported in some studies. Median duration of follow-up in the studies reporting these recurrence rates was 35 (22.5-120) mo in the LG and 34.1 (23.6-120) mo in the CG. At follow-up, local recurrence rate ranged from 2.6% to 15.8% in the LG and from 0% to 26.3% in the CG. A statistically significant difference in local recurrence rate between both groups was only found in one of the studies: Chan et al\[[@B16]\] reported a significant difference in local recurrence rate of 2.8% in the LG and 9.8% in the CG after 31 mo of follow-up (*P \<* 0.001). Four studies reported the local recurrence rate in a study population of only rectal cancer patients. In three of these studies, the local recurrence rate was comparable: 3% in both groups after 34 months of follow-up in the study by Rickert et al\[[@B26]\], 4.8% in the LG and 3.8% in the CG (*P =* 0.875) after almost two years of follow-up in the study by Agha et al\[[@B14]\]; in the study by Keller et al\[[@B22]\] local recurrence was only present in the LG, in 2.6% of patients after 38.2 mo of follow-up (*P =* 0.07). Rottoli et al\[[@B20]\] reported a large difference in local recurrence rate between both groups; 11.4% in the LG and 26.3% in the CG, although this did not reach statistical significance (*P =* 0.07). However, this large difference in recurrence rate between both groups might be explained by the difference in duration of follow-up of 10 mo between both groups in this study; 36 months in the LG and 46 months in the CG.

The rate of distant metastases in the LG en CG was reported in seven studies\[[@B13],[@B14],[@B17],[@B22],[@B23],[@B26],[@B27]\], ranging from 4.3% to 17.3% in the LG and from 0% to 22.6% in the CG. In three of these seven studies\[[@B13],[@B14],[@B27]\], the distant metastasis rate was noteworthy higher in the CG, even though the difference did not reach the statistical significance. In two of these studies both colon and rectal cancer patients were included: Rottoli et al\[[@B27]\] reported a distant metastasis rate of 9.9% in the LG and 21.8% in the CG after a follow-up of approximately four years (*P =* 0.79), and in the study by our group\[[@B13]\] the distant metastasis rate was 16.1% in the LG and 22.6% in the CG after ten years of follow-up (*P =* 0.244). Agha et al\[[@B14]\] only included rectal cancer patients and reported a distant recurrence rate of 13.1% in the LG and 19.2% in the CG (*P =* 0.390). The distant metastasis rate was comparable between both groups in the other four studies.

CONCLUSION
==========

This review of the literature has demonstrated that conversion of laparoscopic colon resection does not seem to significantly increase the postoperative morbidity, while the results after converted laparoscopic resection for rectal cancer are less favorable than those achieved by patients who had a completely laparoscopic surgery. With regard to long-term oncologic outcome, OS and DFS in the case of conversion in laparoscopic colorectal cancer surgery seems to be worse compared to the group of patients in whom resection was successfully completed by laparoscopy. However, it remains difficult to draw a proper conclusion due to the heterogeneity of the long-term oncologic outcomes as well as the inclusion of both colon and rectal cancer patients in most of the studies. Poorer survival in converted patients seems to be multifactorial, including tumor stage as well as inflammatory response secondary to more tissue damage and sequelae of postoperative complications.
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